According to Gram Research analysis, nearly 65% of children with nephrotic syndrome who take steroids develop weaker bones than healthy children their age, with bone density scores significantly lower in the hip and spine. Even with calcium and vitamin D supplements, these children’s bones remain substantially weaker, suggesting that regular bone check-ups and close medical monitoring are essential for children on long-term steroid therapy for kidney disease.
Children with nephrotic syndrome (a kidney disease) take strong steroid medications for long periods, which can weaken their bones. Researchers compared bone strength in 31 children with this disease to 31 healthy children using special X-ray scans. They found that nearly two-thirds of the sick children had weaker bones than normal, even though they were taking calcium and vitamin D supplements. The study shows these children need regular check-ups to monitor their bone health because the steroids they need to treat their kidney disease have a side effect of making bones more fragile.
Key Statistics
A 2026 cross-sectional study of 62 children found that 64.5% of children with nephrotic syndrome had lower bone mineral density than expected for their age, compared to healthy age-matched controls.
In a 2026 study of 31 children with nephrotic syndrome, hip bone density scores averaged -2.18 to -2.47 compared to -0.46 to -0.50 in healthy children, representing substantially weaker bones despite calcium and vitamin D supplementation.
Research from 2026 showed that children with nephrotic syndrome had significantly lower vitamin D blood levels than healthy children, even though they were receiving vitamin D supplements, suggesting supplementation alone may be insufficient.
A 2026 cross-sectional analysis of 62 children revealed that spine bone density scores in children with nephrotic syndrome averaged -1.72 compared to -0.60 in healthy controls, a statistically significant difference indicating weaker bones.
The Quick Take
- What they studied: Whether children taking steroids for kidney disease develop weaker bones than healthy children
- Who participated: 62 children aged 5-14 years: 31 with nephrotic syndrome (kidney disease) and 31 healthy children without the disease
- Key finding: About 65% of children with kidney disease had weaker bones than expected for their age, with bone density scores significantly lower than healthy children
- What it means for you: If your child has nephrotic syndrome and takes steroids, their bones may be weaker than other kids their age. Regular bone check-ups and continued calcium and vitamin D are important, though these supplements alone may not fully prevent bone weakening from steroids.
The Research Details
This was a cross-sectional study, which means researchers took a snapshot in time by comparing two groups of children at the same moment. One group had nephrotic syndrome (a kidney disease where the kidneys leak protein), and the other group was healthy. All children were between 5 and 14 years old and matched by age and gender to make the comparison fair.
The researchers used a special type of X-ray called DXA (dual-energy X-ray absorptiometry) to measure bone density in both groups. This scan is painless and uses very low radiation to measure how much bone mineral is in different parts of the body, like the hip and spine. They also measured blood levels of calcium, phosphate, vitamin D, and other minerals that affect bone health.
The study was conducted at a single hospital center, meaning all participants came from one medical facility. This type of study is good for finding differences between groups but cannot prove that steroids directly cause weaker bones—it can only show that the two groups are different.
This research approach is important because it clearly shows whether children with kidney disease actually have weaker bones in real life. By comparing them to healthy children of the same age and gender, researchers can see if the disease and its treatment truly affect bone strength. The DXA scan is the gold standard tool for measuring bone density, making the results reliable and comparable to other studies.
The study is reasonably well-designed with matched control groups, which strengthens the findings. However, it’s a single-center study with a relatively small sample size (31 children per group), so results may not apply to all children everywhere. The study shows association (weaker bones in sick children) but cannot prove cause and effect. The researchers did not find a clear link between how much steroid medication children took and bone weakness, which is somewhat surprising and suggests other factors may also play a role.
What the Results Show
The main finding was striking: nearly 65% of children with nephrotic syndrome had lower bone mineral density than expected for their age. When researchers measured specific bones, the differences were clear and statistically significant. In the hip (femur neck), children with kidney disease had bone density scores of -2.18 to -2.47, compared to -0.46 to -0.50 in healthy children. In the spine, the scores were -1.72 versus -0.60. These negative numbers mean the sick children’s bones were substantially weaker.
Interestingly, even though all the children with kidney disease were receiving calcium and vitamin D supplements, their bones were still weaker than healthy children. The researchers also found that children with kidney disease had lower vitamin D levels in their blood compared to healthy children, suggesting that supplementation alone may not be enough to prevent bone weakening.
The study looked for a connection between how much steroid medication children had taken over time and their bone weakness, but surprisingly did not find a strong statistical link. This suggests that while steroids are likely part of the problem, other factors related to the kidney disease itself may also contribute to bone weakness.
The research revealed that vitamin D levels were significantly lower in children with nephrotic syndrome compared to healthy controls, which is important because vitamin D is essential for bone health. The study also measured other blood minerals like calcium, phosphate, and parathyroid hormone, which help regulate bone metabolism. These measurements help explain why bones become weaker in children with kidney disease—the disease affects how the body handles minerals needed for strong bones.
This study aligns with existing medical knowledge that long-term steroid use weakens bones in both children and adults. The finding that nearly two-thirds of children with nephrotic syndrome have low bone density is consistent with previous research showing that this is a common complication. However, the lack of a clear dose-response relationship (more steroids = weaker bones) is somewhat unexpected and suggests that future research should investigate other mechanisms, such as how the kidney disease itself affects bone health independent of steroid effects.
The study has several important limitations. First, it only included 31 children with kidney disease from one hospital, so results may not apply to all children everywhere. Second, it’s a snapshot in time rather than following children over years, so we can’t see how bone density changes. Third, the study cannot prove that steroids cause weak bones—it only shows that children taking steroids have weaker bones. Fourth, the researchers didn’t find a clear link between steroid dose and bone weakness, which raises questions about what else might be causing the problem. Finally, the study didn’t track how long children had been sick or other factors that might affect bones.
The Bottom Line
Children with nephrotic syndrome should receive regular bone density check-ups (DXA scans) to monitor for weakening, ideally every 1-2 years while on steroid therapy. Continue calcium and vitamin D supplementation as prescribed, though be aware this alone may not fully prevent bone loss. Encourage weight-bearing exercise and physical activity appropriate for the child’s age and health status, as this helps maintain bone strength. Work closely with your child’s kidney specialist and pediatrician to balance the need for steroids to treat the kidney disease with strategies to protect bone health. These recommendations have moderate to strong evidence support.
Parents and caregivers of children with nephrotic syndrome should prioritize this information, as their children are at clear risk. Pediatricians and kidney specialists treating children with this disease should implement regular bone monitoring. Children who have been on steroid therapy for more than a few months should be evaluated. This research is less relevant for children without kidney disease or those taking steroids for short periods.
Bone weakening from steroids develops gradually over months to years. You won’t see immediate changes, but regular DXA scans every 1-2 years will show whether bone density is stable, improving, or declining. Benefits from exercise and proper nutrition take several months to become apparent. If bone loss is detected, it may take 6-12 months of intervention to see improvement.
Frequently Asked Questions
Do children with nephrotic syndrome have weaker bones?
Yes. Research shows 65% of children with nephrotic syndrome have lower bone mineral density than healthy children their age. This occurs because the steroids used to treat the kidney disease weaken bones over time, even with calcium and vitamin D supplements.
Can calcium and vitamin D supplements prevent bone loss in children taking steroids?
Supplements help but may not fully prevent bone weakening. A 2026 study found children with nephrotic syndrome had lower vitamin D levels and weaker bones despite taking supplements, suggesting additional strategies like exercise and regular monitoring are needed.
How often should children with nephrotic syndrome have bone density scans?
Regular monitoring with DXA scans every 1-2 years is recommended for children on long-term steroid therapy. This allows doctors to detect bone loss early and adjust treatment strategies to protect bone health while managing the kidney disease.
What can parents do to protect their child’s bones during steroid treatment?
Ensure consistent calcium and vitamin D supplementation, encourage weight-bearing exercise like walking or sports appropriate for your child’s health, maintain regular bone density check-ups, and work with your child’s doctor to balance steroid therapy with bone protection strategies.
Is the bone weakness from steroids permanent in children?
Bone loss from steroids can be partially reversible with proper intervention, especially in growing children whose bones are still developing. Early detection through regular scans and aggressive management of nutrition and exercise offer the best chance for bone recovery.
Want to Apply This Research?
- Track steroid medication doses and dates, calcium/vitamin D supplement intake, and physical activity minutes per day. Set reminders for supplement timing and log any bone-related symptoms like pain or fractures.
- Set a daily reminder to take calcium and vitamin D supplements at the same time each day. Schedule 30 minutes of weight-bearing activity (walking, dancing, age-appropriate sports) at least 3-4 times per week. Mark DXA scan appointments on the calendar and set reminders 2 weeks before scheduled tests.
- Create a health dashboard showing steroid doses over time, supplement adherence rates, and physical activity trends. Set quarterly check-in reminders to review bone health goals with your child’s doctor. Track any changes in height or bone-related symptoms. Use the app to prepare questions for medical appointments about bone health.
This research describes an association between nephrotic syndrome treatment and weaker bones in children but does not establish definitive cause-and-effect. This information is for educational purposes and should not replace professional medical advice. Parents of children with nephrotic syndrome should consult with their child’s nephrologist or pediatrician before making any changes to treatment, supplementation, or exercise routines. Individual results vary, and treatment decisions should be based on each child’s specific medical situation. This study was conducted at a single center with a small sample size, so results may not apply universally to all children with this condition.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.